Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MK-2750 in Advanced Solid Tumors
NCT07876128Phase 2Not yet recruiting
- Sponsor
- Merck & Co.
- Start
- Nov 2026
- Primary completion
- Apr 2029
01
Overview
A Phase 2 trial of SKB571 in solid tumor, sponsored by Merck & Co.. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
SKB571
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT07876128.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07876128.